Literature DB >> 21702699

IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C. Part 9: reference procedure for the measurement of catalytic concentration of alkaline phosphatase International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Scientific Division, Committee on Reference Systems of Enzymes (C-RSE) (1)).

Gerhard Schumann1, Rainer Klauke, Francesca Canalias, Steffen Bossert-Reuther, Paul F H Franck, F-Javier Gella, Poul J Jørgensen, Dongchon Kang, Jean-Marc Lessinger, Mauro Panteghini, Ferruccio Ceriotti.   

Abstract

Abstract This paper is the ninth in a series dealing with reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C and the certification of reference preparations. Other parts deal with: Part 1. The concept of reference procedures for the measurement of catalytic activity concentrations of enzymes; Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase; Part 3. Reference procedure for the measurement of catalytic concentration of lactate dehydrogenase; Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase; Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase; Part 6. Reference procedure for the measurement of catalytic concentration of γ-glutamyltransferase; Part 7. Certification of four reference materials for the determination of enzymatic activity of γ-glutamyltransferase, lactate dehydrogenase, alanine aminotransferase and creatine kinase at 37 °C; Part 8. Reference procedure for the measurement of catalytic concentration of α-amylase. The procedure described here is derived from the previously described 30 °C IFCC reference method. Differences are tabulated and commented on in Appendix 1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21702699     DOI: 10.1515/CCLM.2011.621

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  22 in total

1.  Glyphosate-induced liver and kidney dysfunction, oxidative stress, immunosuppression in Nile tilapia, but ginger showed a protection role.

Authors:  Afaf D Abdelmagid; Alshaimaa M Said; Eman A Abd El-Gawad; Sara A Shalaby; Mahmoud A O Dawood
Journal:  Vet Res Commun       Date:  2022-06-30       Impact factor: 2.459

2.  Mediterranean Fast Food: A Leading Cause of Hypercholesterolemia among University Students in Northern Jordan.

Authors:  Moawiah Khatatbeh; Waleed Momani; Zaid Altaany; Reem Al Saad; Abdul Rahman Al Bourah; Omar Melhem; Omar Al Omari
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

3.  Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS-1211, a tissue-nonspecific alkaline phosphatase inhibitor.

Authors:  Sonomi Maruyama; Hester Visser; Takashi Ito; Tharin Limsakun; Hamim Zahir; Daniel Ford; Ben Tao; Cynthia A Zamora; Jeffrey G Stark; Hubert S Chou
Journal:  Clin Transl Sci       Date:  2022-01-12       Impact factor: 4.438

4.  Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein.

Authors:  Setor K Kunutsor; Stephan J L Bakker; Jenny E Kootstra-Ros; Ronald T Gansevoort; John Gregson; Robin P F Dullaart
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

5.  Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism.

Authors:  Wenjuan Yang; Luming Huang; Jinhang Gao; Shilei Wen; Yang Tai; Meng Chen; Zhiyin Huang; Rui Liu; Chengwei Tang; Jing Li
Journal:  Mol Med Rep       Date:  2017-08-21       Impact factor: 2.952

6.  Relationship between alkaline phosphatase and impaired coronary flow in patients with ST-segment elevated myocardial infarction.

Authors:  Efe Edem
Journal:  J Int Med Res       Date:  2018-07-05       Impact factor: 1.671

7.  Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy.

Authors:  Leonardo Gil-Santana; Luís A B Cruz; María B Arriaga; Pryscila F C Miranda; Kiyoshi F Fukutani; Paulo S Silveira-Mattos; Elisangela C Silva; Marina G Oliveira; Eliene D D Mesquita; Anneloek Rauwerdink; Frank Cobelens; Martha M Oliveira; Afranio Kritski; Bruno B Andrade
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

8.  Non-Dose-Dependent Changes in Liver Enzyme Levels of Children With Epilepsy on Treatment With Sodium Valproate.

Authors:  Aduragbenro Deborah A Adedapo; Winifred Eseoghene Demaki; IkeOluwa Lagunju
Journal:  Dose Response       Date:  2020-04-23       Impact factor: 2.658

9.  BCL11A gene DNA methylation contributes to the risk of type 2 diabetes in males.

Authors:  Linlin Tang; Lingyan Wang; Huadan Ye; Xuting Xu; Qingxiao Hong; Hongwei Wang; Leiting Xu; Shizhong Bu; Lina Zhang; Jia Cheng; Panpan Liu; Meng Ye; Yifeng Mai; Shiwei Duan
Journal:  Exp Ther Med       Date:  2014-06-12       Impact factor: 2.447

10.  Concentration of selected liver enzymes across the stages of glomerular function: the associations with PFOA and PFOS.

Authors:  Ram B Jain
Journal:  Heliyon       Date:  2019-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.